A recent study has demonstrated that Jab1/CSN5 enhances epidermal growth factor receptor (EGFR) stability by decreasing EGFR ubiquitination, thereby activating the PI3K/AKT signaling pathway in osteosarcoma cells140. The gene discussed is COPS5; the disease is osteosarcoma.